Inhalation toxicity of brevetoxin 3 in rats exposed for twenty-two days

Environmental Health Perspectives

Volumn 113, Issue 5, 2005, Pages 626-631

  Benson, Janet M ^a   Hahn, Fletcher F ^a   March, Thomas H ^a   McDonald, Jacob D ^a   Gomez, Andrea P ^a   Sopori, Mohan J ^a   Bourdelais, Andrea J ^b   Naar, Jerome ^b   Zaias, Julia ^c   Bossart, Gregory D ^d   Baden, Daniel G ^b  

^a LOVELACE RESPIRATORY RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF NORTH CAROLINA WILMINGTON   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^d FLORIDA ATLANTIC UNIVERSITY   (United States)

Author keywords

Brevetoxin; Immunotoxicity; Inhalation; Neurotoxicity; Rats

Indexed keywords

BREVETOXIN; NEUROTOXIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; BONE MARROW; BRAIN; CELL HYPERPLASIA; CONTROLLED STUDY; DINOFLAGELLATE; ENVIRONMENTAL EXPOSURE; HISTOPATHOLOGY; HUMORAL IMMUNITY; LIVER; LUNG ALVEOLUS MACROPHAGE; MEAN CORPUSCULAR VOLUME; NONHUMAN; NOSE; PLAQUE FORMING CELL; PRIORITY JOURNAL; RAT; RAT STRAIN; RED TIDE; RETICULOCYTE COUNT; SEASHORE;

AEROSOLS; ANIMALS; ANTIBODY FORMATION; BODY WEIGHT; DINOFLAGELLIDA; EUTROPHICATION; INHALATION EXPOSURE; MALE; MARINE TOXINS; OXOCINS; RATS; RATS, INBRED F344;

ANIMALIA; DINOPHYCEAE; KARENIA BREVIS;

EID: 21044442513     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.7497     Document Type: Article

References (27)

1. Abraham WM, Bourdelais AJ, Ahmed A, Sereberiakov I, Baden DG. 2005. Effects of inhaled brevetoxins in allergic airways: toxin-allergen interactions and pharmacologic intervention. Environ Health Perspect 113:632-637.
2. Backer LC, Fleming LE, Rowan A, Cheng Y-S, Benson J, Pierce RH, et al. 2003. Recreational exposure to aerosolized brevetoxins during Florida red tide events. Harmful Algae 2:19-28.
3. Baden DG. 1989. Brevetoxins: unique polyether dinoflagellate toxins. FASEB J 3:1807-1817.
4. Benson JIM, Hahn FF, March TH, McDonald JD, Sopori ML, Seagrave JC, et al. 2004. Inhalation toxicity of brevetoxin-3 in rats exposed for five days. J Toxicol Environ Health A 67:1443-1456.
5. Benson JM, Hahn FF, Tibbetts BM, Bowen LE, March TH, Langley RJ, et al. 2003. Florida red tide: inhalation toxicity of Karenia brevis extract in rats. In: Harmful Algae 2002: Proceedings of the Xth International Conference on Harmful Algae, 21-25 Oct 2002, St. Pete Beach, FL (Steidinger KA, Landsberg JH, Tomas CR, Vargo GA, eds). St. Petersburg, FL:Precision Litho Service, Inc; Florida Fish and Wildlife Conservation Commission and Intergovernmental Oceanographic Commission of UNESCO, 502-504.
6. Benson JM, Tischler DL, Baden DG. 1999. Uptake, tissue distribution, and excretion of brevetoxin 3 administered to rats by intratracheal instillation. J Toxicol Environ Health A 57:345-355.
7. Berman FW, Murray TF. 1999. Brevetoxins cause acute excito-toxicity in primary cultures of rat cerebellar granule neurons. J Pharmacol Exp Ther 290:439-444.
8. Bossart GD, Baden DG, Ewing RY, Roberts B, Write SD. 1998. Brevetoxicosis in manatees (Trichechus manatus latirostris) from the 1996 epizootic: gross, histologic, and immunohistochemical features. Toxicol Pathol 26:276-282.
9. Bourdelais AJ, Campbell S, Benson J, Abraham WM, Naar J, Kubanek J, et al. 2003. Florida's red tide dinoflagellate Karina brevis may modulate its potency by producing a non-toxic competitive antagonist. In: Harmful Algae 2002: Proceedings of the Xth International Conference on Harmful Algae, 21-25 Oct 2002, St. Pete Beach, FL (Steidinger KA, Landsberg JH, Tomas CR, Vargo GA, eds). St. Petersburg, FL:Precision Litho Service, Inc.; Florida Fish and Wildlife Conservation Commission and Intergovernmental Oceanographic Commission of UNESCO, 113-115.
10. Bourdelais AJ, Campbell S, Jacocks H, Naar J, Wright JLC, Carsi J, et al. 2004. Brevenal is a natural inhibitor of brevetoxin action in sodium channel receptor binding assays. Cell Mol Neurobiol 24:553-563.
11. Cattet M, Geraci JR. 1993. Distribution and elimination of ingested brevetoxin (brevetoxin-3) in rats. Toxicon 31-1483-1486.
12. Cheng YS, Zhou Y, Irvin CM, Pierce RH, Naar J, Backer LC, et al. 2005. Characterization of marine aerosol for assessment of human exposure to brevetoxins. Environ Health Perspect 113:638-643.
13. Cunningham AJ, Szenberg A. 1968. Further improvements in the plaque technique for detecting single antibody-forming cells. Immunology 14:599-600.
14. Fleming LE, Backer LC, Baden DG. 2005a. Overview of aerasolized Florida red tide toxins: exposures and effects. Environ Health Perspect 113:618-620.
15. Fleming LE, Kirkpatrick B, Backer LC, Bean JA, Wanner A, Dalpra D, et al. 2005. Initial evaluation of the effects of aerosolized Florida red tide toxins (brevetoxins) in persons with asthma. Environ Health Perspect 113:650-657.
16. Hubbs AF, Minhas NS, Jones W, Greskevitch M, Battelli LA, Porter DW, et al. 2001. Comparative pulmonary toxicity of 6 abrasive blasting agents. Toxicol Sci 61:135-143.
17. Katunuma N, Matsunaga Y, Himeno K, Hayashi Y. 2003. Insights into the roles of cathepsins in antigen processing and presentation revealed by specific inhibitors. Biol Chem 384:883-890.
18. Kirkpatrick B, Fleming LE, Squicciarini D, Backer LC, Clark R, Abraham W, et al. 2004. Literature review of Florida red tide: implications for human health effects. Harmful Algae 3:99-115.
19. Lewis TA, Hartmann CB, McCoy KL. 1998. Gallium arsenide modulates proteolytic cathepsin activities and antigen processing by macrophages. J Immunol 161:2151-2157.
20. Luster MI, Munson AE, Thomas PT, Lauer LD, Germolec DR, Rosenthal GJ, et al. 1988. Development of a testing battery to assess chemical-induced immunotoxicity: National Toxicology Program's guideline for immunotoxicity evaluation in mice. Fundam Appl Toxicol 10:2-19.
21. Naar J, Bourdelais A, Tomas C, Kulbanek J, Whitney PL, Flewelling L, et al. 2002. A competitive ELISA to detect brevetoxins from Karenia brevis (formerly Gymnodinium breve) in seawater, shellfish, and mammalian body fluid. Environ Health Perspect 110:179-185.
22. Pierce RH, Henry MS, Blum PC, Lyons J, Cheng YS, Yazzie D, et al. 2003. Brevetoxin concentrations in marine aerosol: human exposure levels during a Karenia brevis harmful algal bloom. Bull Environ Contam Toxicol 70:161-165.
23. Poli MA, Templeton CB, Thompson WL, Hewetson JF. 1990. Distribution and elimination of brevetoxin-3 in rats. Toxicon 28:903-910.
24. Riese RJ, Chapman HA. 2000. Cathepsins and compartmentalization in antigen presentation. Curr Opin Immunol 12:107-113.
25. Schlesinger RB. 1989. Deposition and clearance of inhaled particles. In: Concepts in Inhalation Toxicology (McClellan RO, Henderson RF, eds). Washington, DC:Taylor and Francis, 191-217.
26. Sudarsanam S, Virca GD, March CJ, Srinivasan S, 1992. An approach to computer-aided inhibitor design: application to cathepsin L. J Comput Aided Mol Des 6:223-233.
27. Van Dolah FM. 2000. Marine algal toxins: origins, health effects, and their increased occurrence. Environ Health Perspect 108(suppl 1):133-141.